cas 1207055-69-3|| where to buy N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)quinoxaline-2-carboxamide

Nom du produit:N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)quinoxaline-2-carboxamide

IUPAC Name:N-(2-cyclopropanecarbonyl-1,2,3,4-tetrahydroisoquinolin-7-yl)quinoxaline-2-carboxamide

Unité d'emballage	Stock disponible	Prix($)	Quantité

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1207055-69-3 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1207055-69-3; Formule moléculaire:C22H20N4O2; Point de fusion:-; Code SMILES:O=C(NC1=CC2=C(CCN(C2)C(=O)C2CC2)C=C1)C1=CN=C2C=CC=CC2=N1; Densité:

: Numéro de catalogue:CM940087; Poids moléculaire:372.43; Point d'ébullition:; N° Mdl:; Stockage:

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

: Tetrahydroisoquinolines; Tetrahydroisoquinoline is an organic compound with the chemical formula C9H11N. It is classified as a secondary amine, obtained from isoquinoline by hydrogenation. The tetrahydroisoquinoline moiety forms the backbone of several natural, synthetic and semi-synthetic drugs approved for the treatment of cancer, pain, gout and various neurodegenerative diseases.